Latest Anticonvulsants Stories
First Branded Product in CNS Portfolio Now Available MAPLE GROVE, Minn., June 30, 2014 /PRNewswire/ -- Upsher-Smith
DUBLIN, June 24, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/x39mrm/global_and)
DeepResearchReports.com adds “2014 Deep Research Report on Global and China Paraldehyde Industry” and “2014 Deep Research Report on Global and China Crotonaldehyde Industry” reports to
Recently FDA Approved Qudexy(TM) XR Offers a New Treatment Option for Managing Specific Seizure Types MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- Results from
WOODCLIFF LAKE, N.J., June 16, 2014 /PRNewswire/ -- Eisai Inc.
WOODCLIFF LAKE, N.J., April 25, 2014 /PRNewswire/ -- Eisai Inc.
Flood Law Group announced today that they are available to investigate the claims of parents of children who suffer from birth defects that are possibly linked to the prescription drug Depakote.
An inexpensive glaucoma drug, when added to a weight loss plan, can improve vision for women with a disorder called idiopathic intracranial hypertension (IIH), according to a study funded by the National Institutes of Health.
In patients with idiopathic intracranial hypertension and mild vision loss, the use of the drug acetazolamide, along with a low-sodium weight-reduction diet, resulted in modest improvement in vision, compared with diet alone.
NEW YORK, April 21, 2014 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) announces a $190
- Emitting flashes of light; glittering.